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Gold nanoprobes for theranostics
What are gold nanoprobes?
Gold nanoprobes (GNPs) are nanometer scale 
particles made of gold in varying shapes and 
sizes. Typical nanoprobes take the form of 
spheres, rods, shells, stars, cages, crescents, 
boxes and prisms with sizes ranging from 2 to 
500 nm. Most probes used in biomedical and life 
sciences applications lie in the range between 10 
and 100 nm. Nanoprobes have been shown to 
function as effective contrast agents for imaging 
and photothermal therapy, and as drug delivery 
vehicles for targeted therapeutics. The ease of 
fabrication, chemical stability, multifunction-
ality and biocompatibility makes GNPs highly 
attractive for diagnostics and therapy.
Background
Theranostics is the term coined to define 
the fusion of therapeutics and diagnostics. 
Theranostics focuses on the integration of 
information from a diverse set of biomarkers 
to create pharmaceutical formulations for a tar-
geted subpopulation where the drug can display 
greater therapeutic efficacy and less toxicity [1,2]. 
Theranostics encompasses a wide range of sub-
jects, including personalized medicine, bioinfor-
matics, proteomics, genomics, pharmacogenom-
ics and molecular imaging to develop efficient 
new targeted therapies with adequate benefit/
risk to patients and a better molecular under-
standing of how to optimize drug selection. 
Figure 1 presents the cycle involved in biomarker 
discovery emanating from population-based 
studies, classification of a clinical phenotype 
and bioinformatics to predict biomarkers in a 
given subpopulation. From biomarker discov-
ery to delivery of theranostics, nanotechnol-
ogy can play a vital role in its ability to deliver 
diagnostic sensors and therapeutic formulations. 
Nanotechnology encompasses the creation and 
utilization of materials at the level of atoms, 
molecules, and supramolecular structures. 
Unique size-dependent electronic, optical, 
thermal and mechanical properties of nano-
materials are being exploited today in diverse 
areas ranging from computer chips to biology 
and medicine. The high surface area:volume 
ratio renders nanoparticles with the ability to 
functionalize with surface moieties that can be 
used to target specific sites, sequester proteins 
or even silence a gene inside a living cell. Many 
different types of nanoparticles including, gold 
nanorods (GNRs), carbon nanotubes and sili-
con nanowires have been proposed, synthesized 
and their physical properties have been inves-
tigated in different applications depending on 
their size and shape. Gold nanostructures in this 
context are unique due to their chemical inert-
ness, nontoxicity and ease of surface functionali-
zation with different molecular structures such 
as thiols, amines, nitrates and phosphines to 
create active sensors and formulations that can 
interact with biological materials both in vitro 
and in vivo.
Gold is a byproduct of supernova nucleo-
synthesis and has fascinated human beings for 
thousands of years. It has been described in the 
Egyptian texts as early as 2600 BC. The fabrica-
tion of gold nanoparticles has been documented 
as early as the 4th century when Roman crafts-
men used the particles to create stained glass and 
pottery. Michael Faraday’s fascination with ruby 
gold and his methods to synthesize reproduc-
ible and stable gold suspensions with a particle 
size between 6 ± 2 nm and his investigations 
into the physical properties of gold colloids may 
Gold nanoprobes have become attractive diagnostic and therapeutic agents in medicine and life sciences 
research owing to their reproducible synthesis with atomic level precision, unique physical and chemical 
properties, versatility of their morphologies, flexibility in functionalization, ease of targeting, efficiency 
in drug delivery and opportunities for multimodal therapy. This review highlights some of the recent 
advances and the potential for gold nanoprobes in theranostics.
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have been the starting point of modern nano-
technology [3]. Over the years many different 
shapes and sizes of gold nanostructures have 
been synthesized. Interest in gold nanoparticles 
has increased almost exponentially in the last 
10 years in biological engineering (Figure 2). 
Today gold nanoparticles as plasmonic nano-
structures are used as sensors and drug delivery 
agents in applications such as detection of patho-
gens, photothermal transducers for minimally 
invasive therapy, the treatment of blood clotting 
related disorders, and contrast agents in imaging 
and in therapeutic formulations to name a few. 
The utilization of nanoparticles such as gold for 
theranostic purposes for simultaneous imaging, 
diagnosis and therapy in one step with the ability 
to monitor treatment efficacy is expected to offer 
a variety of options in nanomedicine. 
In this review we attempt to provide our 
perspective on the use of gold nanoprobes in 
diagnostics and therapeutics with an empha-
sis on cancer. The synthesis and morphology 
of different types of gold nanoprobes and their 
size ranges are dealt with in detail. Optical 
absorption and scattering cross-sections of dif-
ferent types of gold nanoprobes are compared 
against conventional organic dyes (Table 1) and 
their utility in sensing and molecular imaging 
is discussed. The electron thermalization events 
in gold nanoprobes leading to their applica-
tion in photothermal and radiofrequency (RF) 
therapy to kill cancer cells are discussed. While 
the physical properties of gold are intrinsic in 
nature, we also showcase and discuss biologically 
relevant extrinsic factors for successful targeting, 
namely surface functionalization of nanoprobes, 
molecular targeting and cellular internalization 
that can enable drug and gene delivery. Finally, 
we look into the limited data on the biological 
toxicity of GNPs. The review concludes with 
potential futuristic insights and their relevance 
in detection and treatment.
Synthesis, morphology & properties 
of GNPs
GNPs come in different shapes and sizes. 
Control over shape, size and chemical com-
position of GNPs itself is a challenging area of 
research that eventually determines the surface 
functionality and activity. The most common 
shapes are spherical particles, rods, shells, cages, 
prisms and stars. Figure 3a presents the transmis-
sion electron microscopy images of spheres, rods 
and stars, and their optical absorbance (Figure 3b). 
Spectral comparison in Figure 3C shows their util-
ity in surface-enhanced Raman spectroscopy 
(SERS). The following paragraphs review the 
synthesis and physical properties of GNPs. 
Stable and spherical gold nanoparticles ranging 
between 10 and 100 nm can be formed in a num-
ber of ways. The classic method is gold reduction 
from HAuCl
4
 via citrate at 100°C, and was devel-
oped in the early 1950s by Turkevich et al. [4–6]. 
By varying the concentration of the gold versus 
citrate, one can tune the size of the gold nanopar-
ticles synthesized. Recently, Turkevich’s method 
has been revisited and compared with its variants, 
namely UV-initiated reduction and ascorbate 
reduction [7,8]. Results showed that control of the 
simple Turkevich process by the reduction condi-
tions is sufficient to define particles’ shape and 
size in a wide interval. The UV-initiated particle 
growth in contrast resulted in more spherical-like 
particles even at larger sizes. Ascorbate reduction 
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Figure 2. Gold nanoprobe research trends in biological engineering.
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ensured the best spherical definition of the par-
ticles. Extensive networks of gold nanowires were 
also formed as a transient intermediate in the cit-
rate reduction method [7]. These gold nanowires 
were shown to exhibit nonlinear optical prop-
erties and also contributed to the dark appear-
ance of the reaction solution before it turned 
ruby-red. Another popular fabrication method 
is called the ‘Brust synthesis’ developed in 1994 
by Brust and Schiffrin et al. [9,10]. In this method, 
organic liquids such as toluene, reducing agents 
such as NaBH
4
 and tetraoctylammonium bro-
mide (TOAB) are used to synthesize gold colloid 
particles from HAuCl
4 
. TOAB, a phase transfer 
agent, acts as a stabilizer; however, it does not 
form a strong bond with gold, which may cause 
particle aggregation after a few weeks. Another 
more recently developed method by Perrault et al. 
uses hydroquinone in an aqueous environment to 





This method can produce mono-
dispersed gold n anospheres in sizes ranging from 
50 to 200 nm [11].
A simple but versatile variation of the spheri-
cal gold nanoparticle is the nanorod [12]. GNRs 
can be synthesized with different aspect ratios 
and are particularly useful in imaging, because 
they produce strong and tunable plasmonic 
resonance properties in the red to near-infrared 
(NIR) region of the electromagnetic spectrum 
[13–16]. GNRs and silver nanorods can be pre-
pared using electrochemical and seed-medi-
ated growth methods [12,17–20]. In the electro-
chemical method, a platinum cathode and gold 
anode are immersed in an electrolytic solution 
in an ultrasonic bath at 36°C containing hexa-
decyltrimethylammonium bromide and a small 
amount of hydrophobic cosurfactant tetra-
dodecylammonium bromide. The surfactant 
serves to stabilize and prevent the aggregation 
of nanoparticles. Controlled electrolysis at 3 mA 
for 30 min leads to the formation of nanorods. In 
the seed-mediated approach, citrate-capped gold 
nanoparticle seeds with a diameter of 3.5 nm are 
used for the nucleation and reduction of gold salt 
in the presence of cetyl trimethyl ammonium 
bromide and ascorbic acid. This produced nano-
rods with a 4.6 ± 1 aspect ratio. It was found that 
addition of silver nitrate enhanced the formation 
and aspect ratio of nanorods. While the initial 
yield was poor using this method (~4%), nano-
rods of high yield (90%) using seed-mediated 
growth have been reported by slightly increasing 
the pH of the solution [21]. 
Gold-coated dielectric nanoparticles are 
called gold nanoshells [22–24]. This configuration 
of a dielectric core coated with a metal nanoshell 
occur naturally in the growth of Au-Au
2
S 
nanoparticles. Silica-coated gold nanoshells 
are produced by growing silica nanoparticles 
Table 1. Gold nanoprobes: optical properties and applications.
Gold nanoprobes Optical property Application
Nanospheres Cabs = 2.93 × 10
-15 (m2), at lmax =528 nm, 
for 40 nm particle diameter
Csca =1.23 × 10
-14 (m2) at 560 nm, for 
80 nm particle diameter [51]
Contrast agents in OCT, 
photothermal heating, cellular 
uptake
Nanoshells Cabs = 5 × 10
-14 (m2) and Csca =3.25 × 10
-14 
(m2) at lmax =892 nm, for 140 nm particle 
diameter [52]
Contrast agents in OCT, 
photothermal heating, TPS 
and cellular uptake
Nanorods Cabs = 1.97 × 10
-14 (m2) and  Csca = 1.07 × 
10-14 (m2) at lmax =842 nm, for effective 
radius = 21.86 nm and aspect ratio R = 3.9 
[51]
Contrast agents in OCT, 
photothermal heating, TPS 
and cellular uptake
Nanocages Cabs = 7.3 × 10
-15 (m2), Csca =0.8 × 10
-15 (m2)  
at lmax =825 nm, for 36 nm particle [42]
Contrast agents in OCT, 
photothermal heating, TPS, 
cellular uptake 
Nanostars SERS enhancement factor of 5 × 
103 averaged over the 52 nm nanostars for 
633 nm excitation [38]




Cabs =1.66 × 10
-20 (m2) at lmax =778 nm, 
e = 1.08 × 104 M-1cm-1 at 778 nm [51]
Conventional organic dyes 
used in imaging
Rhodamine 6G e = 1.16 × 105 M-1cm-1 at 530 nm [51] Conventional strongly 
absorbing organic dye used in 
imaging
Cabs: Absorption cross section; Csca: Scattering cross section; e: Molar extinction coefficient; NIR: Near infrared; 
OCT: Optical coherence tomography; SERS: Surface-enhanced Raman spectroscopy; TPS: Two-photon scattering.
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Figure 3. Physical properties of some select nanoprobes. (A) Transmission electron microscopy images of gold nanoprobes: 
(a) spheres; (b) rods; and (c) stars, (B) optical absorbance versus wavelength for the three different morphologies of gold nanoprobes and 
(C) SERS spectra comparison of 2 MPy absorbed on: (a) nanostars (140 nm), (b) nanorods (65 × 30 nm) and (c) nanospheres (150 nm).
Reproduced with permissions from [33,227].
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and coating then with a layer of gold to form 
a core–shell structure. Reduction of tetraethy-
lorthosilicate in ammonium hydroxide and etha-
nol produces silica nanoparticles of 40–120 nm 
in diameter. Next, colloidal gold nanoparticles 
are used as seeds to stick to the silica nanopar-
ticles, which form a discontinuous gold layer. 
Further gold is added by reducing HAuCl
4
 in 
the presence of potassium carbonate and form-
aldehyde. By tuning the diameter of the core 
and thickness of the shell, one can tune the opti-
cal properties of the nanoshells to a wide range 
of wavelengths, including the ‘water window’, 
which is the IR range of the electromagnetic 
spectrum [25]. Gold nanoshells possess remark-
able optical properties that differ dramatically 
from solid spheres. Another type of nanopar-
ticle, gold nanoclusters (2–6 nm), has been a 
topic of recent interest because of its unique size, 
which may be advantageous in cellular uptake 
as well as in nuclear targeting, in addition to the 
unique optical and electrical properties exhib-
ited by gold nanoclusters [26–29]. Despite their 
small size, these nanoclusters were found to be 
stable because the thiolate groups form a protec-
tive layer around gold clusters, improving their 
stability and f unctionality [30,31]. 
Star polyhedral gold nanocrystals were syn-
thesized recently by colloidal reduction of gold 
with ascorbic acid in water under ambient condi-
tions [32]. Two distinct classes of star nanocrys-
tals were identified: multiple-twinned crystals 
with fivefold symmetry and monocrystals. These 
respective classes correspond to icosahedra and 
cuboctahedra, two Archimedian solids, with 
preferential growth of their {111} planes. Due 
to this preferential growth, the {111} faces of the 
original Archimedean solids grow to become 
tetrahedral pyramids, the base of each pyramid 
being the original polyhedral face. By assuming 
a star morphology, gold nanocrystals increase 
in proportion to the exposed {111} planes and 
have low surface energy that could be highly 
useful for creating stable and biologically active 
surfaces. Gold nanostars exhibit high plas-
monic resonance due to juxtapositioning of the 
tips that radially emerge from the core making 
these structures useful for imaging by dark field 
microscopy, SERS and plasmonics [33–37]. 
Gold nanocages also represent a unique design 
in the field of nanomaterials for biology and med-
icine [38–42]. Gold nanocages with porous walls 
can be formed using simple galvanic replacement 
reaction in an electrochemical bath between 
solutions containing metal precursor salts and 
silver nanostructures prepared through polyol 
reduction. The electrochemical potential dif-
ference drives the reaction with gold reduction 
depositing on the surface of the silver nanocubes. 
Typically, HAuCl
4
 is used as a metal precursor, 
the resultant gold is deposited epitaxially on the 
surface of the silver nanocubes, adopting their 
underlying cubic form. Concurrent with this 
deposition, the interior silver is oxidized and 
removed, together with alloying and de-alloy-
ing to produce hollow and eventually, porous 
structures that are commonly referred to as gold 
nanocages. By controlling the molar ratio of sil-
ver to HAuCl
4
, the extinction peak of the result-
ant nanostructures can be continuously tuned 
from the blue (400 nm) to the NIR (1200 nm) 
region of the electromagnetic spectrum (Figure 3). 
Calculations suggest that the magnitudes of 
both scattering and absorption cross-sections of 
nanocages can be tailored by controlling their 
dimensions, as well as the thickness and poros-
ity of their walls. This novel class of hollow 
nanostructures is expected to find use as both a 
contrast agent for optical imaging in early-stage 
tumor detection and as a therapeutic agent for 
photothermal cancer treatment [43–45]. 
Newer shapes and morphologies of nanoprobes 
and multifunctional composite nanostructures 
are being researched. The future of nanoprobe 
synthesis lies in creative techniques for combining 
the geometries of two or more probes to enable 
sharp tuning of optical properties and effective 
targeted therapy. For example, one could imagine 
nanorods with needle- shaped structures along 
the longitudinal axis with surface plasmon bands 
at lower energies, for use as SERS probes, and in 
SPR imaging, drug delivery and photothermal/
RF therapy. The use of gold with other materi-
als, namely magnetic and polymeric materials, to 
create new morphologies for imaging and therapy 
needs to be further investigated to make it cost 
effective for simultaneous imaging and therapy. 
However, the creation of new morphologies are 
only justified if the new materials produce surface 
plasmon bands at lower energies, enable sensi-
tive colorimetric contrast for imaging, can be 
utilized as improved SERS probes or have use-
ful photothermal effects for therapy. Finally, the 
mass production of different types of nanoprobes 
and their impact on the environment needs to be 
thoroughly investigated.
Surface plasmon resonance for 
optical imaging
Surface plasmon resonance constitutes the col-
lective oscillation of electrons that may exist at 
the interface of two mediums with dielectric 
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constants of opposite signs, for instance, a metal 
and a dielectric [46,47]. The propagation constant 
of the surface plasma wave propagating at the 
interface between a dielectric and metal is given 
by the following expression: 
k m s2 m s2
1/2
= +b f h f h` j







is the dielectric constant of metal and hs is the 
refractive index of the dielectric. A material may 
propagate surface plasmon waves provided, e
mr
 
is <-hs2. The most common metals that support 
this condition at optical wavelengths are gold and 
silver. Nanoprobes of gold and silver scatter light 
intensely in the visible and NIR region of the 
electromagnetic spectrum depending upon the 
size, shape and aggregation of the particles and 
distance between particulate islands. The scatter-
ing of light by nanoparticles is explained by the 
Mie scattering theory [48] and Maxwell-Garnett 
theory [49]. The Mie-Gans theory is the exten-
sion of Mie’s theory for gold particles for particle 
size much smaller than the excitation wavelength 
[50]. Depending on the particle size, aggregation 
and shape, gold nanoparticles in a medium can 
appear as red, blue or violet in color, thus provid-
ing colorimetric contrast (Figure 4). The color scat-
tering property can be useful in biological and 
cellular applications due to surface functionali-
zation of the particles with appropriate moieties 
for labeling studies with a white light source and 
an inexpensive light microscope [51]. Gold nano-
particles in the size range commonly employed 
(~40 nm) show an absorption cross-section five 
orders of magnitude larger than conventional 
absorbing dyes, while the magnitude of light scat-
tering by approximately 80 nm gold nanospheres 
is five orders higher than the light emission from 
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Figure 4. Colorimetric contrast of nanoprobes. (A) Transmission electron microscopy image of gold nanocages. (B) Colorimetric 
contrast of silver nanocubes and gold nanocages and their optical absorbance versus wavelength. Gold nanocages prepared by reacting 
5 ml of a ~0.2 nM silver nanocube (edge length ~40 nm) suspension with different volumes of a 0.1 mM HAuCl4 solution. The 
corresponding UV-visible absorbance spectra of silver nanocubes and gold nanocages.  
Reproduced with permission from [42].
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optical properties of different nanoprobes and 
compares it with conventional organic dyes 
g enerally used for biological imaging. 
The metal nanoshells are interesting nano-
probes, because of their silicon dioxide dielectric 
core and a gold shell. Due to the higher concen-
tration of the electric field in the dielectric core, 
the propagation constant is highly sensitive to 
variation in the optical properties of the dielec-
tric adjacent to the metal layer. Variation in the 
thickness of the metal layer and the dielectric 
layer can produce a shift in the frequency of the 
surface plasmon resonance, thereby producing 
unique colors of metal nanoshells in the visible 
and near infra-red region of the electromag-
netic spectrum. For example, the conventional 
NIR dye indocyanine green has an absorp-
tion cross-section of approximately 10-20 m2 at 
approximately 800 nm while the cross-section 
of the absorbing nanoshells is approximately 4 × 
10-14 m2, an approximately million-fold increase 
in absorption cross-section [53]. 
GNRs possess, in addition to the surface 
plasmon band around 528 nm seen in gold 
nanospheres, a band at longer wavelengths due 
to the plasmon oscillation of electrons along 
the long axis of the nanorods. Thus, the mode 
corresponding to the plasmon maximum of the 
nanorods lies in the desirable NIR region, thus 
making GNRs potentially useful for in vivo 
applications as NIR radiation is benign to nor-
mal cells and tissues. The magnitude of the NIR 
absorption and scattering (C
abs
 = 1.97 × 10-14 m2 
and C
sca
 = 1.07 × 10-14 m2 and at l = 842 nm) of 
nanorods with r
eff
 = 21.86 nm is comparable to 
that of nanospheres and nanoshells, at a much 
smaller size or volume [52].
Gold nanocages have displayed surface plas-
mon resonance peaks around 800 nm, a wave-
length commonly used in optical coherence 
tomography (OCT) imaging [39]. OCT meas-
urements on tissue samples embedded with nan-
oprobes indicate that these gold nanocages have 
a moderate scattering cross-section of approxi-
mately 8.10 × 10-16 m2 but a very large absorption 
cross-section of approximately 7.26 × 10-15 m2, 
suggesting their potential use as a new class of 
contrast agents for optical imaging [39]. 
Gold nanostars [35–37] exhibit a short wave-
length plasmon band (nanostar core) in the mid-
visible region and a long-wavelength plasmon 
band (nanostar arms), which appears following 
nucleation and evolves over time in the NIR 
region [35]. The short and long plasmon peaks 
are attributed to the plasmon modes associated 
with the inner core and branch tips, respectively. 
An interesting aspect of the gold nanostar geom-
etry is the shifting of plasmon resonance with 
an increase in the size of the star. As the star 
size increases the short plasmon band centered 
around 550 nm, usually assigned to the plasmon 
band of spherical particles, becomes increas-
ingly red-shifted as the spherical core diameter 
increases in size from 27 to 57 nm. At the same 
time, the long plasmon band, associated with the 
rod-like star branches, also undergoes a red shift 
due to lengthening of branches as well as an over-
all increase in star size. Due to the sharp nature 
of the branching tips, gold nanostars could be 
used as E-field enhancers with the enhancement 
primarily near the sharp edges and corners. The 
local surface plasmons oscillating in the direc-
tion of the branch and confined at the tips would 
mainly be excited by components of the inci-
dent E-field in the same direction. It is therefore 
anticipated that the tips would exhibit varying 
enhancements for any given excitation snapshot 
taken at 633 nm. Initial studies on SERS sig-
nal showed that nanostars exhibited significant 
enhancement in SERS intensity. As the diam-
eter of nanostar increased from 45 to 116 nm, 
the SERS enhancement factors increase from 
2.0 × 103 to 3.63 × 103 [35]. While the reported 
SERS enhancement factors are averaged over 
the entire star, significant E-field enhancement 
could be attained in theory by increasing the 
number of tips, and reducing the size of the core 
and its flatness. The nanostar E-field enhance-
ment, and thus SERS efficiency, originate from 
an intricate interplay of star size, spectral overlap 
between surface plasmon peaks, excitation wave-
length, the number of branches per star surface 
area, branch aspect ratio, branch length and 
general star morphology [35]. Further investiga-
tion is needed to elucidate the dependence of the 
physical factors on the plasmon resonance and 
the associated Raman signal enhancement. The 
choice of GNPs for biological imaging depends 
on the application and the expected response, 
optical resonance wavelength, the extinction 
cross-section, and the relative contribution of 
scattering to the extinction with changes in the 
nanoparticle dimensions. 
Gold nanoprobe-based diagnostics 
 n Sensors
Diagnostic techniques based on gold nanopar-
ticles involve in vitro sensors to detect polynu-
cleotide or proteins [54–58]. In these assays, GNPs 
are capped with appropriate surface moieties to 
target oligonucleotides or proteins followed by 
characterization, which can be conducted by 
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such methods as atomic force microscopy, scan-
ning electron microscopy, Raman Spectroscopy 
and other techniques [59–63]. Sub-attomolar 
concentrations of oligonucleotides have been 
detected using complementary oligonucleotide-
capped gold nanoparticles via high-resolution 
surface plasmon resonance with signal amplifi-
cation [64]. This method has been extended to 
determine p53 cDNA, a polynucleotide tumor 
suppressor responsible for cellular apoptosis that 
is frequently mutated in cancer. In this study, the 
SPR signal changes were reported to be depend-
ent on the p53 cDNA concentration. For target 
p53 cDNA concentrations of 100 and 300 fM, 
the corresponding net reported SPR angular 
shifts were found to be 0.0018 and 0.0030°, 
respectively. p53 protein dysfunction is asso-
ciated with poor prognosis and could be used 
as a molecular indicator for understanding the 
pathology of the disease and progression [65]. 
Gold nanoparticles were modified with detec-
tor monoclonal antibody and horseradish per-
oxidase (for signal amplification). The presence 
of target protein p53 causes the formation of 
the sandwich structures (magnetic beads–tar-
get protein–AuNP probes) through the inter-
action between the antibodies and the antigen 
p53. The horseradish peroxidase at the surface 
of AuNPs catalytically oxidized the substrate to 
generate optical signals with a sensitivity level of 
5 pg ml-1 in less than 2 h. The study compared 
these results to the common antibody–antigen 
biochemical method known as ELISA, which 
has a sensitivity of 0.125 ng/assay for p53 [65]. 
In another recently reported study on GNP 
sensitivity, an oligonucleotide derived from the 
human p53 gene with a one-base substitution 
was distinguished from oligonucelotide with 
wild-type sequences by a colorimetric change 
of the GNP solution with a change in pH 
[66]. All these reports are positive indicators of 
gold nanoparticles in future disease diagnosis 
because of their unique physical properties and 
i mprovement over conventional methods.
 n Imaging
Compared with existing imaging techniques, 
optical imaging using GNPs is relatively simple. 
Nanoparticles are intense light scattering agents 
and therefore simple dark field optical imaging 
could in principle be used to provide color con-
trast to image cells tagged by bioconjugated 
GNPs. The application of gold bioconjugates as 
contrast agents for vital imaging of precancers 
was demonstrated with cancer cell suspensions, 
3D cell cultures, and normal and neoplastic 
fresh cervical biopsies [67]. It was demonstrated 
that gold conjugates can be delivered topically 
for imaging throughout the whole epithelium. 
These contrast agents have the potential to 
extend the ability of vital reflectance microscopy 
for in vivo molecular imaging.
Nanoshells have been used as color contrast 
agents to target Her2 (human epidermal growth 
factor receptor associated with breast cancer) in 
SK-BR-3 cells [25,68,69]. A significant increase 
in optical contrast under dark field conditions 
caused by Her2 expression was observed in 
Her2-positive cells targeted with anti-Her2-
labeled nanoshells compared with cells targeted 
by either anti-IgG-labeled nanoshells or cells 
not exposed to nanoshell conjugates. Nanoshells 
are also optimal candidates for OCT. OCT 
has been performed using gold nanoshells at 
1310 nm in water and turbid tissue-simulating 
phantoms to which nanoshells were added. A 
monotonic increase in signal intensity and atten-
uation with increasing shell and core size was 
observed. Threshold concentrations for a 2-dB 
OCT signal intensity gain were determined for 
several nanoshell geometries. For the nanoshell 
with the largest backscatter (a nanoshell with a 
291 nm core diameter and 25 nm shell thick-
ness) a concentration of 109 nanoshells/ml was 
necessary to produce this signal increase. 
GNRs conjugated with an antibody to the 
EGF receptor have been used to target cancer 
cells overexpressing Her2. Dark field images 
were obtained by utilizing nanoparticle scatter-
ing. After imaging, photothermal damage was 
induced by laser excitation of the nanoparticles 
[51]. This work provided a method for detect-
ing malignant and nonmalignant cells while 
simultaneously providing a route for targeted 
therapy by photothermal ablation. In a parallel 
study, GNRs of different aspect ratios were used 
to detect multiple cell surface markers on can-
cer stem cells [70–74]. Cancer stem cells are cells 
responsible for the initiation and progression of 
malignant tumors [38,39]. Detection of three cell 
surface markers frequently expressed on cancer 
stem cells, CD44, CD42 and CD49f, was pos-
sible using dark field spectroscopy and this was 
validated by flow cytometry [75]. These studies 
demonstrate the utility and advantages of gold 
nanoparticles in molecular cancer imaging. 
Gold nanoparticles have also found a place 
as contrast agents in optoacoustic tomography 
(OAT) [76,77]. OAT is a novel medical imag-
ing method that uses optical illumination and 
ultrasonic detection to produce deep tissue 
images based on light absorption. For example, 
www.futuremedicine.com 1795future science group
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abnormal angiogenesis in advanced tumors, 
which increases the blood content of the tumor, 
is an endogenous contrast agent for OAT. Due to 
their strong optoacoustic signal, gold nanoparti-
cles (NPs) are also excellent as contrast agents. 
To target NPs to specific breast cancer cells, the 
anti-Her2/neu antibody was utilized. Anti-Her2/
neu specifically binds cell surface receptors on 
SK-BR-3 cells. In a series of in vitro experiments, 
Herceptin® (a monoclonal antibody that binds 
to HER2/neu) conjugated to 40 nm NPs (mAb/
NPs) selectively targeted human SK-BR-3 breast 
cancer cells. The breast cancer cells were detected 
and imaged by OAT in a gelatin phantom that 
optically resembled breast tissue. Sensitivity 
experiments show that a concentration as low 
as 109 NPs/ml were detectable at a depth of 
6 cm, demonstrating its feasibility in deep tissue 
imaging of solid tumors [76,77]. Recently, drug-
loaded aptamer–gold nanoparticle conjugates 
have been used with CT imaging and therapy 
of prostate cancer in cell cultures [78]. The result-
ing prostate-specific membrane antigen aptamer-
conjugated GNP showed more than fourfold 
greater CT intensity for a targeted LNCaP cell 
(an androgen-sensitive prostate cancer cell) than 
that of nontargeted PC3 prostate cancer cells. 
Furthermore, after loading the prostate-specific 
membrane antigen aptamer-conjugated GNPs 
with doxorubicin, the GNPs were significantly 
more potent to the targeted LNCaP cells than 
against nontargeted PC3 cells. 
The inherent luminescence properties of noble 
metal nanoparticles have been exploited for bio-
sensing and imaging [79–86]. Photoluminescence 
from noble metals was first reported in 1969 and 
later observed as a broad background in SERS 
[87]. In single photon luminescence of metals, 
excitation of electrons from the d-band to the sp-
band to generate electron–hole pairs takes place. 
The electrons and holes are then scattered on the 
picosecond time scale with partial energy trans-
fer to the phonon lattice, and finally recombina-
tion of electrons and holes resulting in photon 
emission. Two-photon luminescence (TPL) was 
described by Boyd et al., and is considered to be 
produced by a similar mechanism as single pho-
ton luminescence but with relatively weak sig-
nals [88]. The weak TPL signals can be amplified 
by several orders of magnitude if they are pro-
duced from roughened metal substrates, thereby 
opening up a new area of GNPs for two photon 
imaging [88]. Plasmon resonant TPL is attrac-
tive for nonlinear optical imaging of biological 
samples with 3D spatial resolution. GNRs are 
particularly appealing as TPL substrates because 
their longitudinal plasmon modes are resonant 
at NIR, where the absorption of water and bio-
logical molecule is minimized [89–91]. Moreover, 
nanorods have larger local field enhancement 
factors than nanoparticles due to their reduced 
plasmon damping [89]. The TPL signal from a 
single nanorod was shown to be 58-times larger 
than the two-photon fluorescence signal from 
a single rhodamine molecule [89]. TPL imag-
ing using GNRs was first used to image single 
nanorods flowing inside a mouse blood vessel 
(Figure 5) [89]. Following this study, GNRs were 
used as contrast agents in TPL imaging of cancer 
cells in 3D tissue phantoms 75 mm deep. The 
TPL intensity from gold-nanorod-labeled can-
cer cells was three orders of magnitude brighter 
than the two-photon autofluorescence emission 
intensity from unlabeled cancer cells at 760 nm 
excitation. Other studies using GNRs in two 
photon imaging have shown the utility of nano-
rods in imaging [92–95]. The rough star-shaped 
geometry of gold nanostars could also be highly 
useful in TPL studies. Studies incorporating 
magnetic particles with gold have exploited the 
multifunctional features constituting MRI and 
photoluminescence imaging [96–99]. Approaches 
to develop multifunctional nanostructures with 
multimodal functionalities (e.g., in dual imag-
ing, dual therapy, or targeting and therapy) will 
have significant implications if they are tailored 
to treat a specific disease condition. However, 
such advances focusing on specific applications 
will require the needed support mechanism from 
funding agencies and clinicians.
Ultra-sensitive Raman measurements in single 
living cells were demonstrated by exploiting the 
SERS [100,101]. Colloidal gold particles (60 nm 
in size) that are deposited inside cells as ‘SERS-
active nanostructures’ resulted in strongly 
enhanced Raman signals of the native chemi-
cal constituents of the cells [102–109]. Particularly 
strong field enhancement was observed when 
gold colloidal particles formed colloidal clusters. 
The strongly enhanced Raman signals allow 
Raman measurements of a single cell in the 
400–1800 cm-1 range with a 1 µm lateral reso-
lution in relatively short collection times (1 s for 
one mapping point) using 3–5 mW NIR excita-
tion. SERS mapping over a cell monolayer with 
1 µm lateral resolution shows different Raman 
spectra at almost all places, reflecting the inho-
mogeneous chemical constitution of the cells. 
Intracellular detection and imaging of multiple 
SERS probes in zebrafish [110] and multiple met-
als in single bacterium [111] are other notewor-
thy efforts in gold nanoparticle-based detection. 
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Gold nanostars constitute a class of nanoparticles 
that have been recently shown to be useful SERS 
probes. Recently measured SERS enhance-
ment factors suggest an interesting correlation 
between the size of the nanostar (52–116 nm) 
and SERS efficiencies, which were found to be 
relatively consistent across different star samples, 
with an enhancement factor estimated as 5 × 103 
averaged over the 52 nm nanostars for excitation 
633 nm [35]. Nanostars could be quite interest-
ing as nanotags as each arm of the star could 
be used as a plasmonic transducer for sensing 
biomolecules [112,113].
In summary, GNPs are excellent candidates 
for biological sensing and medical imaging 
applications. Their strong signal, resistance 
to photobleaching, chemical stability, ease of 
synthesis, simplicity of conjugation chemistry 
and biocompatibility make GNPs an attractive 
contrast agent for imaging of cells and tissues. 
Several types of GNP morphologies are available 
today to choose from, with tailored functional 
moieties for molecular imaging. Exploiting gold 
nanoprobes with conventional techniques such 
as MRI, CT and OCT will enable selective 
















Figure 5. In vivo imaging of single gold nanorods in mouse ear blood vessels. 
(A) Transmission image with the two blood vessels indicated. Dotted contour lines are provided to 
guide the eye. (B) TPL image of gold nanorods (red dots) flowing through the blood vessels. Image 
was compiled as a stack of 300 frames collected continuously at a rate of 1.12 s per frame. The 
excitation power at the sample was 18 mW with an excitation wavelength of 830 nm; image size is 
175 × 175 µm. The bright signal beneath the lower blood vessel is the autofluorescence from a hair 
root. The streaking is due to sample drift during imaging. (C) Overlay of the transmission image (light 
blue) and a single-frame TPL image. Two single nanorods (red spots) are superimposed by a linescan 
(white). (D) TPL intensity profile from the linescan in (C). The background (~750 a.u.) is due to 
autofluorescence from the blood vessel and the surrounding tissue. The similar intensities of the red 
spots indicate the detection of single nanorods.  
Reproduced with permission from [89].
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in vivo with higher selectivity using appropri-
ate morphologies. Appropriate in vivo imaging 
depends on the optical absorption or scatter-
ing properties in specific wavelength windows, 
targeting surface functional moieties (e.g., 
Ex: IGF1R, Her2, EpCAM and EGFR), and 
imaging modalities with sufficient resolution 
approaching the single cell level. Particles from 
hybrid metallic materials, such as gold, silver 
and iron, conjugated with polymer systems can 
provide for multiple functionalities for multi-
modal therapeutics. Opportunities in these 
areas exist and can be exploited further through 
pathology-based engineering solutions that can 
only be developed through interactions between 
engineers, scientists and clinicians. 
Photothermal therapy
Unlike conventional pharmacological approaches 
(Block Buster Model) towards therapy, nano-
probes are utilized as molecular targeting agents 
in combination with photothermal vectors for 
selective killing of cancer cells. By using specific 
surface moieties that can target diseased cells 
followed by heating the nanoprobes with NIR 
light, selective killing of cancer cells and tissues 
can be achieved in principle without destroy-
ing the surrounding normal and healthy cells 
and tissues. This could translate into minimally 
invasive treatment options and also prevent the 
devastating side effects of conventional meth-
ods such as chemotherapy and radiation therapy. 
These methods also have future applications in 
personalized medicine, which is the idea of treat-
ing an individual, not just the disease. In the case 
of targeted nanoparticles, personalized medicine 
would entail determining the surface molecules 
or receptors present on an individual’s diseased 
cells and using these markers to s pecifically 
t arget those individual cells. 
The heating effect on light absorption in GNPs 
is a result of the electron dynamics in metallic 
lattices [114–118]. Several effects can occur when 
gold nanoparticles are irradiated with light; these 
are surface scattering of electrons, electron–pho-
non coupling and electron–electron thermaliza-
tion. Due to the high electron density in met-
als, electron–electron interactions are strong 
enough to thermalize the electron gas within 
the duration of the exciting laser pulse. When 
light is radiated on the metallic nanoparticles, 
the electrons absorb the photon energy, lead-
ing to a nonequilibrium temperature difference 
between the electron gas and the lattice directly 
after the laser pulse. Electron–phonon collisions 
then give rise to the excitation energy exchange 
between the electron subsystem and the lattice, 
thereby enabling a thermal equilibrium. Studies 
on the electron dynamics of gold nanoparticles 
and nanorods were studied by El Sayed et al., 
using femtosecond spectroscopy [119]. In their 
studies a kinetic trace recorded at 530 nm after 
excitation with 800 nm femtosecond laser pulses 
produced deviations in the signal intensity ver-
sus time profile at an early stage suggesting a 
finite electron–electron thermalization event, as 
opposed to phonon–phonon interactions, which 
would have produced a straight line without any 
deviations [119]. They also studied the effect of 
size and shape of the nanoparticles on electron-
phonon relaxation. The measured electron–pho-
non relaxation times were independent of parti-
cle size and shape for gold in the investigated size 
range of 15–48 nm, eliminating the influence of 
electron-surface scattering as a dominant energy 
relaxation pathway. The relaxation dynamics 
of the excited electrons in a nanoshell of gold 
sulfide nanoparticles coated with an outer layer 
of gold were reported by Averitt et al., who found 
a lifetime of 1.7 ps for nanoshells, similar to the 
results on pure gold nanoparticles [24]. Similarly, 
studies in ultra-fast relaxation dynamics of gold 
nanocages found similar relaxation times [115]. 
Therefore, GNPs primarily undergo similar exci-
tation of electrons causing lattice heating upon 
irradiation with a laser with no dependence on 
the size and shape of the particle.
The small size and the rapid heating abil-
ity of GNPs within a very small area are quite 
attractive for selective heating of cancer cells 
with an appropriate light source thereby lead-
ing to the concept of photothermal therapy. In 
the first such studies, gold nanoshell-mediated 
photothermal destruction of cancer cells was 
demonstrated in an animal model [120]. In 
this study, near infra-red radiation absorbing 
nanoshells (109/ml, 20–50 µl) were injected 
(~5 mm) into solid tumors (~1 cm) in female 
severe combined immunodeficient mice. Within 
30 min of the injection, tumor sites were exposed 
to NIR light from a laser (820 nm, 4 W/cm2, 
5 mm spot diameter, <6 min). Temperature was 
monitored via a phase-sensitive, phase-spoiled 
gradient-echo MRI. Magnetic resonance tem-
perature imaging demonstrated that irreversible 
tumor damage occurred (DT = 37.4 ± 6.6° C) 
within 4–6 min. Controls that were exposed to 
a saline injection rather than nanoshells expe-
rienced significantly reduced average tempera-
tures after exposure to the same NIR light levels 
(DT <10°C). These average temperatures were 
obtained at a depth of approximately 2.5 mm 
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below the surface. Histological examination 
of nanoshell-treated tumors indicated thermal 
damage including coagulation, cell shrinkage 
and loss of nuclear staining. Following this 
study, nanoshells were also targeted to surface 
receptors namely Her2, which is a growth factor 
receptor that is commonly seen in more aggres-
sive breast cancer cells. Then, photothermal 
ablative therapy was administered to selectively 
destroy the cancer cells [121]. The advantage of 
GNP-based approaches as opposed to conven-
tional approaches is the ability to accomplish 
targeting of tumor tissue at the cellular level by 
exploiting both size (50–500 nm) and speci-
ficity, which is possible via modification with 
targeting molecules. This ensures minimal 
damage to surrounding healthy tissue and vital 
organs. Several groups have demonstrated that 
GNP internalized cells or GNPs in the vicinity 
of cancer cells can be irradiated with suitable 
wavelength laser pulses to generate temperatures 
of approximately 70–80°C to achieve necrotic 
cell death due to thermal ablation [122–124]. This 
observation has been translated in vivo using 
mouse models where nanoshells have targeted 
tumor tissues passively via the enhanced per-
meability and retention (EPR) effect, which is 
a result of transendothelial transport via com-
promised tight junction formation in tumor tis-
sue leading to ‘leaky vasculature’ and also the 
lack of lymphatic drainage at tumor locations 
[125,126]. Another factor that is important is the 
dose of GNPs delivered to the tumor tissue. It 
has been demonstrated that a small difference in 
the dose of GNPs delivered to cancer cells can 
make a significant difference in the efficiency 
of tumor ablation [127]. For prostate cancer cells 
it was recently determined that an average of 
approximately 5000 gold nanoshells with peak 
absorption in the NIR region was needed to 
achieve tumor cell elimination [128]. In addition 
to delivery via the EPR effect and thermal abla-
tion of tumor tissue, GNPs can also be function-
alized to specifically target tumor cells, deliver 
antiproliferation or apoptosis drugs or stimuli to 
control tumor growth, and create chemotactic 
gradients to attract immune cells, such as mono-
cytes for tumor clearance [129]. As discussed in 
the section above, the thermal properties of gold 
nanoparticles are unaltered by changes in size 
and shape. Therefore, GNPs including nano-
particles, nanoshells, nanorods, nanocages and 
nanostars have shown the ability to selectively 
destroy cancer cells by utilizing targeting mol-
ecules and NIR heating [74,120,130]. Finally, the 
optical properties of GNPs have been used to 
develop microscopy, namely absorption, scatter-
ing, polarization and photothermal microscopy 
[131–135]. Finally, the photothermal properties of 
nanoparticles could potentially be used as a sur-
gical tool in parts of the body considered inacces-
sible using traditional surgical methods. Along 
similar lines, administering targeted therapy by 
disrupting specific genes or proteins in cells and 
tissues could lead to a new class of opportunities 
in therapy. These efforts will require appropri-
ate probe design and careful simulation of the 
electromagnetic and temperature fields to deliver 
a specific dose of energy for a desired biological 
effect.
RF-mediated therapy
RF-mediated therapy (RFA) is a minimally 
invasive treatment option for focal malignant 
diseases and is beneficial to surgery because it 
can reduce morbidity and mortality, is cost effec-
tive, is suitable for real-time image guidance and 
could be implemented on an outpatient basis. 
RFA involves the use of high temperatures to 
heat the tumor tissue and kill the cancer cells 
with minimal injury to normal tissues [136]. 
During RFA, a high alternating current of 
approximately 480 KHz is passed into the tumor 
through an electrode, which causes ionic agita-
tion and frictional heat production, leading to 
cell death. RFA is a viable treatment option for 
inoperable tumors of the liver, lungs and bone. 
While gold nanoparticles (5–100 nm in diam-
eter) have been shown to interact with shortwave 
RF waves to produce heat (~300,000 W/g of 
gold) [137–141], the plasmon absorption property 
of gold nanoparticles (which is in the range of 
520 to 530 nm) is not effective for photother-
mal therapy. Recent work by us and others have 
shown that the photon luminescence property 
of GNRs, because of their tunable absorbance 
in the NIR region (600–1200 nm), makes them 
excellent optical imaging agents as well as effi-
cient and more effective photothermal agents 
due to their nonisotropy [70,77,89]. Although 
NIR-mediated ablation has shown promise, the 
efficacy is limited by treatment options that are 
practical and capable of treating deep-seated 
tumors (>2–3 cm deep). However, RF has the 
potential to overcome the penetration depth 
issues. Multimaterial nanoparticles (compris-
ing of gold and magnetic particles) will have the 
potential to be responsive to RF treatment and 
alternating magnetic frequency, facilitating long-
term possibility. When conjugated with tumor 
targeting agents such as monoclonal antibodies, 
folate, peptides or aptamers, these dual agents 
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could be used for simultaneous targeting and 
multimodal therapy by RF ablation and moni-
toring by imaging (MRI). If selective ablation 
could be administered at sites where the con-
centration of nanoparticles is above a threshold 
(potentially at a tumor site due to targeting) 
because of localized enhancement of ablation 
using low level RFA, then only tumor cells at 
the tumor site will be killed and the normal cells 
could potentially be left unaffected or subjected 
to a dose sufficiently minimal to not induce 
cytotoxicity. In the past, RF treatments that use 
macroscopic electrodes tend to be painful due to 
damage to tissues surrounding the electrodes. 
However, the use of micro/nanoelectrodes could 
make this technique less invasive and more 
effective. Photothermal heating using RF waves 
could be highly useful for selective killing of 
cancer cells that are p retargeted using GNPs.
GNP interactions with biological 
systems
While the above sections primarily discussed the 
intrinsic factors namely the synthesis, morphol-
ogy, optical absorption, surface plasmon reso-
nance and electron thermalization properties of 
GNPs, in this section, we showcase extrinsic 
factors for successful application of theranos-
tics using GNPs. Some of them include surface 
functionalization, prevention of aggregation and 
targeted delivery. Evaluation of the toxicity of 
GNPs used in vivo is also an important require-
ment that needs to be evaluated prior to appli-
cation although most GNPs in the size ranges 
discussed are considered nontoxic. This section 
details these issues using examples that may or 
may not directly pertain to cancer but in general 
are applicable to theranostics.
 n Functionalization, targeting & 
delivery of GNPs to target cells
GNPs provide unique opportunities to accom-
plish delivery of targeted therapeutics (i.e., drug 
or gene delivery to specific locations for cancer 
treatment). Targeted therapy offers significant 
advantages over free drugs administered sys-
temically in the form of improved stability, site-
specific release and elimination of harmful side 
effects due to interaction with nontarget tissues. 
This process, however, is a complex problem and 
involves design strategies to enable conjugation 
of the drug or gene to the nanoparticle, targeting 
to the cells or tissue of interest and controlled 
release of the drug, while at the same time over-
coming issues with transit through the body 
or nontargeted tissue, nonspecific delivery or 
biodistribution, and clearance from the system 
or effects of residual GNPs within the system. 
Although several of these issues have not been 
completely addressed, in vitro and animal studies 
using GNPs have shown tremendous potential to 
enhance drug delivery to target cells and reduce 
toxicity of the free drug to nontarget organs to 
result in an overall increase in the ‘therapeutic 
index’, an indicator of therapy efficacy.
Surface modification of GNPs
The primary purpose of surface modification 
is the prevention of aggregation and solubiliza-
tion in aqueous solution. To accomplish this, a 
suitable ligand molecule needs to be identified 
to accomplish binding via mechanisms such as 
chemisorption, electrostatic attraction or hydro-
phobic interaction to the GNP. In addition to 
consideration of affinity to the GNP, the interac-
tion of the ligand with the medium of suspen-
sion also plays an important role in the selection 
of an appropriate ligand. Coverage using hydro-
phobic molecules such as thiols [142–144], amines 
or phosphines [145], trioctylphosphine oxide [146], 
triphenylphosphine [147], TOAB [148] and oleic 
acid [149] have been used to prevent aggregation 
or precipitation. Synthesis of GNPs is typically 
accomplished in organic solvents whereas most 
biological applications require transfer to and 
solubility in aqueous solvents. In the event that 
the particle cannot be synthesized with the lig-
and of interest, phase transfer via mechanisms 
such as ligand exchange [150], ligand modifica-
tion [151], additional coating [152], polymer coat-
ing [153] or silanization [154] could be done to 
ensure compatibility and stability in an aqueous 
environment. Ligands with hydrophilic chains 
offer solubility in aqueous environments while 
hydrophobic chains act as a protective capping 
layer and ensure stability in a wide variety of bio-
analytical environments. An extremely common 
and versatile technique used for surface modifi-
cation and functionalization is the use of thiols, 
organosulfur compounds containing a carbon-
sulfhydryl group (-C-SH or R-SH) where the 
R is usually an alkene. Thiols have the unique 
property of self-assembling on gold and hence 
GNP surfaces are commercially available in a 
modified form with several functional groups 
for immobilization of various biomolecules on 
GNP surfaces. Weisbecker et al. have shown the 
formation of self-assembled monolayers on gold 
colloids in 50% ethanol solution in the pres-
ence of alkenethiols with positive and neutral 
functional groups [142]. They demonstrated that 
chain length and functionality of the terminal 
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groups are critical variables that significantly 
affect flocculation of GNP dispersions and sug-
gest that it occurs due to a loss of surface energy 
on the gold particles. Further, coverage with 
thiol monolayers also serves to protect the GNPs 
from etching. Lin et al., used a two-step process 
to functionalize GNPs with thiols [143]. They 
first suspended tetrachloroauric acid by triso-
dium citrate in water. The chloride and citrate 
physisorbed on GNPs and was first displaced 
by thioctic acid, which in turn was exchanged 
with thiols containing the desired functionality 
in the subsequent step. From a biological stand-
point, a critical issue in the design of nanoparti-
cle drug- and gene-delivery carriers is the size of 
the nanoparticle itself as it is important to avoid 
accidental clearance. This can occur via several 
mechanisms including the excretory system, the 
reticuloendothelial system or the mononuclear 
phagocytic system. On the other hand, aggre-
gation or agglomeration of particles within the 
body can also occur at nonspecific locations and 
pose problems such as inflammation and altered 
cellular function. A major factor affecting clear-
ance of particles or aggregation within different 
tissues and organs is the particle size. In addition, 
surface modification techniques using naturally 
occurring polymers such as dextran, chitosan, 
pullulan and surfactants, including sodium 
oleate and dodecylamine, have also been used 
to assess distribution, to avoid detection by the 
host immune system and to minimize immune 
responses in specific tissues [155]. Several groups 
have also used polyethylene glycol (PEG) for 
surface modification to ensure a ‘stealth mode’ 
that enables long-term presence in circulation 
without clearance via inhibition of recognition 
for clearance through phagocytosis. Akiyama 
and Niiodome et al. demonstrated that graft-
ing of GNRs with PEG prevented nonspecific 
interactions with plasma proteins and inhibited 
agglomeration in circulation, while serving to 
avoid clearance via the reticuloendothelial sys-
tem [156,157]. They also determined that increas-
ing the density of PEG molecules on the surface 
of the nanorods improved in vivo delivery. In 
addition to modification with PEG, functionali-
zation with several other biomolecules has also 
been accomplished. Using mechanisms such as 
covalent, noncovalent and electrostatic binding 
various biomolecules, such as avidin [158], biotin 
[158], biotin-modified with amine [159] and car-
boxylic groups [160], DNA [161], RNA [162], pro-
teins [163], peptides[164], enzymes [165] and anti-
bodies [166] have been attached to GNPs. Lee 
et al., [167] modified GNPs with primary amine 
groups to create intracellular delivery vehicles 
for therapeutic siRNA. Amine modified GNPs 
possess a net positive charge and are capable of 
forming stable polyelectrolyte complexes with 
negatively charged siRNA–PEG conjugates with 
cleavable disulfide groups that can be cleaved 
in the reductive environment of the cytoplasm. 
Targeting & internalization of GNPs
The ability to target and internalize GNPs into 
cells and the nucleus at preferred sites is an 
intriguing concept in the treatment of diseases 
and in understanding the internal workings of 
cells. A major advantage of GNPs over other 
types of nanoparticles is the ease of function-
alization via self-assembly using thiol chemis-
try and the commercial availability of various 
thiol-linked peptides, proteins and antibodies. 
Functionalization is important not only to target 
nanoparticles to specific tissues but also to direct 
internalization to specific locations within cells 
where the molecular cargo can be released to 
perform targeted functions. When the circula-
tory system is used, the vascular endothelium 
provides an ideal target as endothelial cells at 
different locations in the body differ greatly in 
the expression of surface antigens [168,169] and 
allow for specific localization to different parts 
of the body. Targeting of tumor tissue within 
the body has been accomplished without any 
surface functionalization, rather relying on the 
leaky vasculature at those locations by exploit-
ing the EPR effect. Demonstrations of specific 
targeting to tissues and organs such as the lymph 
node using anti-CD4 [170], liver using heparin 
coatings [171], endothelial cells and leukocytes 
using various inflammatory markers [172], and 
retinal pigment epithelial cells using polylactide 
[173] have been accomplished. Recently, Choi 
et al., [174] demonstrated that modification of 
GNPs with transferrin, a glycoprotein that binds 
iron strongly but reversibly, can be used to target 
tumor cells within various tissue. Using tail vein 
injections of GNPs modified with both transfer-
rin and PEG, they found that the biodistribu-
tion of GNPs was independent of transferrin. 
However, within a particular tissue such as the 
liver, the number of GNPs in hepatocytes was 
small whereas the number of GNPs in nonparen-
chymal cells was significantly higher indicating 
preferential accumulation in cancer cells. 
Uptake and cellular internalization of GNPs 
is a highly intriguing and complex process that 
is not yet well understood. Nanoparticles can 
enter the cells through different routes that may 
be available to them in parallel and factors that 
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favor a specific entry route are not well under-
stood. Cellular internalization to the cytoplasm 
and nucleus have been widely accomplished 
using cell penetrating peptides including: 
  Penetratin™, a patented basic cell-penetrating 
peptide that enables cellular uptake of various 
large, hydrophilic cargos [175];
  TAT, derived from a transactivator of tran-
scription, and other cell penetrating peptides 
[164,175] that contain a high abundance of pos-
itively charged amino acids can facilitate the 
transport of both small and large molecular 
cargo across cell membranes;
  Anti-actin targeting molecules [176], which 
have a high affinity for intracellular actin;
  Sweet arrow peptide [177], which acts in ways 
similar to TAT peptides;
  Nuclear localization sequences that are essen-
tially peptide sequences that target the pro-
teins via the cytosolic nuclear transport recep-
tors or nuclear pore complex;
  Receptor-mediated endocytosis peptides [178] 
such as clathrin, which is a major component 
of vesicles and plays a key role in the transloca-
tion of vesicles into the cytoplasm via 
e ndocytosis. 
The binding of transferrin (discussed pre-
viously) to its receptor on the cell surface has 
also been exploited to accomplish intracellular 
translocation [179]. Gene delivery approaches 
have used GNPs capped with polyethylenimine 
[180], a polycationic molecule widely used in 
DNA transfections due to its ability to inter-
act with negatively charged DNA. Liposomal 
delivery using vesicles made out of a bilayer of 
phospholipids to encompass aqueous cargo for 
intracellular deliver has also been explored [181]. 
It is now believed that this process occurs due 
to endocytosis rather than fusion with the cell 
membrane [182]. Finally, strategies such as micro-
injection [183] to subcellular locations and ultra-
sound based sonoporation [184] have been used to 
transport GNPs into cells. In summary, further 
investigations are necessary for understanding 
the pathways available to cells for internaliza-
tion. The control of such pathways could lead to 
delivery of drugs at specific sites inside the cells 
that can alter the fate of the cell.
Drug & gene delivery using GNPs
GNPs can be used for the delivery of vari-
ous types of drugs, DNA, RNA, siRNA and 
proteins. Once the GNPs reach their targeted 
destination within the body, efficient release 
of therapeutic agents is necessary for effec-
tive therapy. Release can be accomplished via 
triggers that can be actuated either internally 
using chemical/biological activation or exter-
nally using physical stimulation. Glutathione-
mediated release is a commonly used technique 
that exploits the difference in levels of thiols in 
the extracellular and intracellular environment. 
Glutathione is the most abundant thiol species 
in the cytoplasm and the major reducing agent 
in cellular biochemical processes, and in the 
case of GNPs modified with thiol functional 
groups can cause exchange of thiol groups on the 
GNPs resulting in release of functional group 
[185]. Polizzi et al. showed that GNPs can also 
be used to deliver diatomic therapeutic agents 
such as nitric oxide (NO) [186]. NO plays an 
important role in the regulation of blood ves-
sel tone and controlled release is important 
under clinical conditions such as hypertension. 
Efficient storage and controlled release of NO 
has been demonstrated via covalent linkage with 
tiopronin-protected gold nanoclusters to form 
of acid labile N-diazeniumdiolate NO donors 
to enable storage and release of NO on demand 
[186]. In another example of molecular therapeu-
tics, Hone et al., [187] show the generated singlet 
oxygen for photodynamic treatment of cancer 
by mobilizing the surface of the monolayer pro-
tected gold particles with photosensitizers, such 
as phthalocyanines, which on photoactivation 
generate singlet oxygen.
GNPs can be used as efficient carriers of 
DNA molecules. DNA–GNPs have been shown 
to enter a wide variety of cell types. Transport 
of DNA molecules is one form of gene therapy 
where target DNA is introduced directly to 
the cells’ nucleus. Passive targeting has been 
accomplished by relying on the electrostatic 
interactions of thiol-linked DNA with GNPs 
[188], which resist enzymatic degradation [189] 
and can be released via glutathione in the cyto-
plasm following charge-based transport of the 
DNA to the nucleus [190]. Thomas et al. used 
hybrid nanoparticle transfection vectors that 
were created using functionalized GNPs with 
branched polyethylenimine and showed highly 
improved transfection efficiency using a cell 
culture model [191]. Photochemical release or 
uncaging of DNA immobilized to the surface 
of GNPs was demonstrated by Rotello et al. by 
changing the nature of GNPs from cationic to 
anionic via immobilization of a photocleavable 
O-nitrobenzyl ester linker and a quaternary 
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ammonium salt end group [192]. Oishi et al. 
accomplished covalent linkage of nucleic acids 
to GNPs for siRNA delivery by modifying the 
siRNA with a thiol group for self-assembly to 
the surface of the particle [193]. Finally, Verma 
et al. used GNPs for the delivery of proteins 
using various strategies, including complemen-
tary electrostatic interactions with the nanopar-
ticle in conjunction with glutathione-mediated 
release [194]. Chitosan-coated particles strongly 
adsorb insulin and have been used for cellular 
delivery of insulin [195]. 
 n Biological toxicity of GNPs
Gold in the macro- or micro-scale is chemically 
inert and biocompatible. At the nanoscale it is 
widely accepted that particles larger than 5 nm 
behave similar to bulk gold whereas at sizes of 
<5 nm the chemical reactivity of gold is sig-
nificantly altered [196]. Au
55
 clusters at 1.4 nm 
diameters exhibited significant toxicity com-
pared with their 18 nm counterpart on most 
human cancer as well as healthy cell lines [197]. 
However, the response of cells and biological 
systems to smaller GNPs is still not fully under-
stood. Over the past few years with the rapid 
increase in GNP technologies for biomedical 
applications, several groups have sought to 
address this critical problem. Prior to the use 
in vivo, it is important to evaluate both acute 
and long-term effects due to potential inter-
action of GNPs with tissues, organs, circula-
tion and the respiratory tract. This needs to be 
accomplished by evaluating the toxic effects 
of GNPs at various levels of cellular organiza-
tion. Cellular level studies provide the highest 
specificity (i.e., the ability to identify molecular 
mediators and signaling mechanisms in cells); 
however, their relevance (i.e., translation of 
results from the cell to higher levels of organi-
zation) is poor. Intact tissues and organs provide 
greater relevance at the cost of lower specificity, 
whereas patient level studies offer the highest 
relevance albeit with poor specificity. Extensive 
evaluation of the various factors that influence 
biocompatibility and toxicity of GNPs is criti-
cal for sustained and safe development of novel 
enabling nanotechnologies.
Cellular level studies
Use of GNPs for in vivo biomedical applications 
inevitably results in GNP interaction with cells 
and tissue in the body where GNPs are exposed 
to physiological fluids such as blood, saliva, the 
extracellular matrix and even the cytoplasm of 
a cell. In vitro applications involve interaction 
with cell culture media and other physiological 
buffers. Most physiological fluids and buffers are 
a complex mixture of proteins, ions, electrolytes, 
amino acids, vitamins and other chemicals such 
as drugs and antibiotics. Physical interaction of 
GNPs with the constituents of physiological 
fluids can change physiochemical properties 
such as size, aggregation, surface charge and 
chemical/biological specificity influencing sub-
sequent interaction with cells and tissues. High 
ionic strength solutions are known to cause GNP 
aggregation due to electrostatic screening [198]. 
Adsorption of proteins, particularly plasma pro-
teins in blood, alters the behavior of the nanopar-
ticle, changing the biological specificities and 
interactions by causing the particle to adopt the 
properties of the adsorbed shell [199–201]. Protein 
adsorption has also been found to reverse or 
change the charge on GNRs from cationic to 
anionic [202] with the potential to enable new 
functions such as receptor-mediated endocytosis, 
enabling cellular internalization [203].
Intracellular drug- and gene-delivery studies 
require an extensive understanding of the mech-
anisms of uptake of GNPs into cells, localization 
within the cell and changes in cellular signaling 
mechanisms as a consequence of uptake [204,205]. 
Cells typically accomplish internalization of par-
ticles and macromolecules through processes 
such as phagocytosis (>500 nm) [206,207], pino-
cytosis and different types of receptor-mediated 
endocytosis (<500 nm) [206,207]. Receptor-
mediated endocytosis is known to be the pri-
mary mechanism of cellular internalization of 
GNPs smaller than 100 nm in size [175,208,209]. 
Functionalization of GNPs with ligands such 
as transferrin and clathrin have been used to 
enable endocytosis [209]. Modification of GNP 
surface charge and phobicity has also been 
exploited to enable direct internalization [210]. 
Once inside the cell, GNPs have been found 
to remain trapped in vesicles in the cytoplasm 
[202,205,209,211]. Release into the cytoplasm or 
transfer to the nucleus requires further modifi-
cation with biomolecules to enable penetration 
of the nuclear membrane [175]. However, other 
groups claim nuclear internalization without 
specific modifications [196,212]. 
Overall, in vitro studies using cell culture 
models have generated significant information 
on intracellular transport of GNPs and cell 
structure and function, including changes in cell 
signaling via oxidative stress response pathways 
[213], impaired proliferation [214], compromised 
motility [215,216] and apoptosis [217]. However, 
these studies have provided little knowledge 
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on toxicity, especially in the context of in vivo 
application. This can be attributed to diversity 
in the types of cells and cell lines evaluated and 
the large variability in GNP types, sizes, doses, 
surface charge, functionalization and targeting 
molecules. GNP cellular toxicity studies will 
therefore benefit from standardization of proto-
cols and systematic ana lysis of gene and protein 
expression using relevant cellular level models. 
In vivo studies
Toxicity of GNPs in vivo can result from a 
variety of interactions of GNPs locally and 
systemically within the body. In blood GNPs, 
especially unmodified small diameter nanorods, 
could potentially initiate clotting or erythrocyte 
lysis. Small GNPs comparable in size to bacte-
rial antigens or viruses could elicit an immune 
response causing activation of leukocytes or 
white blood cells and local and systemic inflam-
mation. Despite significant research towards 
various applications, this aspect of GNPs has 
not been extensively evaluated. Inhalation is an 
important pathway that could lead to harmful 
effects of GNPs and cause inflammation of the 
respiratory tract and breathing disorders. Once 
GNPs enter the system either via the respira-
tory tract, blood circulation or within various 
tissues, the presence of GNPs within the body if 
detected can result in accumulation in different 
organs responsible for clearance of waste such as 
the liver, spleen and kidneys. Accumulation of 
GNPs in various organs without clearance from 
the system can potentially be a significant hazard 
as they are highly stable and more resistant to 
clearance via metabolism or the excretory sys-
tem, which could result in altered cellular func-
tion and/or chronic inflammation due to activa-
tion of the host immune system. Therefore, the 
design of GNPs for in vivo biomedical applica-
tions requires careful consideration of various 
factors including size, shape, chemical and bio-
logical reactivity in various tissues and within 
the respiratory and circulatory systems to ensure 
no adverse reactions occur due to the presence 
of GNPs in vivo.
Relatively few studies have sought to evalu-
ate the direct and indirect effects of GNP inter-
actions in blood. Dobrovolaskia et al. exam-
ined the immunological response of blood to 
nanoparticles and found that unmodified GNPs 
caused lysis of erythrocytes or red blood cells 
[218]. However, other studies evaluating citrate-
modified GNPs smaller than 50 nm in diameter 
were found to be compatible with blood as they 
did not induce clotting, platelet aggregation or 
activation of the complement system [219]. The 
ability of GNPs to elicit an immune response 
and cause local and systemic inflammation due 
to direct interaction with blood or indirectly 
via presentation by antigen-presenting cells has 
not been extensively evaluated. However, anti-
gen-bound GNPs have been used to enhance 
the immune response towards antigens [220]. 
Studies examining the interaction of GNPs and 
GNP aggregates in the respiratory tract of mice 
resulted in increased asthmatic response indicat-
ing potential to cause inflammation, signifying 
the need to exercise caution. 
GNP biodistribution studies performed using 
animal models have provided interesting insights 
into accumulation of GNPs in various organs 
and toxicity. Using mice, Hillyer et al. showed 
that size of GNPs (<10 nm) facilitated trans-
port across the gastrointestinal tract indicating 
the possibility of clearance from the body [221]. 
De Jong et al. extensively evaluated the effect 
of size on biodistribution using a rat model and 
tail vein injections [222]. Unmodified 10, 50, 100 
and 250 nm GNPs were administered and after 
24 h the animals were sacrificed and blood and 
various organs were collected and analyzed. For 
all sizes of GNPs, the majority were found in the 
liver and the spleen. However, clear differences 
were observed for the 10 nm particles, which 
were localized in the blood, spleen, liver, testis, 
lung, and brain whereas other sizes were detected 
only in the blood, liver and spleen. Sonavane et 
al. [223] performed a similar study in mice using 
unmodified GNPs 15, 50, 100 and 200 nm. 
They found similar results to the previous study 
and also found that 15 and 50 nm particles were 
able to pass the blood–brain barrier, which has 
important clinical implications in drug delivery 
targeting brain tissue. Clearance of GNPs from 
the body was also found to be size dependent. 
Large GNPs injected into mice were found to 
remain even 2 years after in vivo delivery [224]. 
This is thought to be due to the inability of the 
kidney to filter and clear particles smaller than 
6 nm [225]. Most applications use GNPs larger 
than 6 nm and these particles were found to be 
removed from blood via the reticuloendothelial 
system and accumulate in the liver and spleen 
[222,226]. Figure 6 presents the histological map 
of PEGylated gold nanoparticles in different 
organs, namely muscle (Figure 6b), liver (Figure 6C) 
and lungs (Figure 6D). 
Conclusion & future perspective 
Gold has fascinated human beings since time 
immemorial and colloidal gold has been known 
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for centuries. In the past 10 years, there has been 
tremendous interest in studying the physical 
properties of different types of GNPs and their 
optical properties (namely surface plasmon reso-
nance) and investigating their interactions with 
biological materials. The fundamental interest 
in GNPs arises due to their enhanced absorp-
tion cross-section compared with conventional 
organic dyes that are also prone to photobleach-
ing effects. The ease of synthesis, chemical sta-
bility, wide variety of surface functionalization 
protocols and the electron thermalization effects 
resulting in heating has made GNPs prime 
candidates for future forays in nanomedicine. 
Cellular level studies show that gold nanopar-
ticles can enter the cells and even the nucleus 
of cells with simple surface functionalization 
protocols. These aspects of gold can find appli-
cations in in vitro diagnostics and in understand-
ing cellular uptake pathways and localization 
mechanisms. GNPs have been demonstrated as 
contrast agents in OCT, OAT and CT imaging 
in vivo. The heating effects have been shown to 
destroy cancer cells in mouse models with the 
potential to be used in surgery in places that 
are considered inoperable using conventional 
surgical methods (e.g., large arteries, veins or 
the brain). 
Several areas of GNPs need further inves-
tigation. In the area of synthesis new types of 
GNP morphologies that combine one or more 
of the already existing shapes need to be inves-
tigated with an intent to create structures with 
intense and relevant plasmon modes to study the 
electron transfer process in live cells. The drive 
towards developing structures with plasmon 
bands at lower energies, increased absorption 
and scattering cross-sections, and with calori-
metric tunability could be useful in single cell 
diagnostics. In the area of functionalization, new 
methodologies and protective coatings that can 
impart stability in a wide variety of biological 
environments, enable ease of aqueous solubility 
and finally prevent aggregation must be investi-
gated. Factors such as nanoparticle size, surface 
charge, hydrophobic/hydrophilic interactions, 
and bioaccessibility become highly important 
for the successful interrogation of cells. 
An area that needs critical investigation is the 
elucidation of nanoparticle uptake pathways, 
which are still not clear. A better understand-
ing of nanoparticle interaction and uptake could 
lead to effective targeting for increased treatment 
efficacy. Although several nanoparticle assays 
exist, live cell quantification assays have been 
scarce [70]. Quantification coupled with uptake 
and internalization studies can provide valuable 
information on compartmentalized dynamics as 
well as precise information on localization and 
drug release. 
For the most part, gold is considered nontoxic. 
However, recent reports show that at particle 
diameters of less than 5 nm, the surface reactiv-
ity of gold increases. Au
55
 clusters with diam-
eters of 1.4 nm have been reported to be toxic 
in a variety of human cancer as well as healthy 
cell lines [197]. Therefore, it is vital to conduct 
long-term studies of its distribution in different 
cellular organelles and to understand the size 
and surface modification effects in vivo. The 
ability of GNPs to elicit an immune response 
and cause local and systemic inflammation due 
to direct interaction with blood or indirectly via 
presentation by antigen-presenting cells has not 
been extensively evaluated. Relatively few studies 
exist on the direct and indirect interactions of 
GNPs in blood. Instrumentation that integrates 
simultaneous imaging and guided therapy with a 
multimodal functionality in a single step will be 
attractive for basic studies as well as in clinical 
applications. While numerous studies exist, a 
specific and significant application is still lack-
ing. Progress need not necessarily encompass a 
particle performing multiple functions. A sig-
nificant step could also follow the notion of “less 
is more”. Despite the advances and obstacles, the 
future of nanoparticle-based theranostics looks 
Figure 6. Histology images (40×) of PEGylated gold particles in different 
organs 24 h after injection. (A) Tumor; (B) muscle; (C) liver; and (D) lung.
Reproduced with permission from [228].
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Executive summary
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  The electron thermalization state of GNPs upon absorption of light in the near-infared region makes them promising as photothermal 
agents that can target and selectively kill diseased cells with minimal disruption to the normal cells and tissues.
  Simultaneous imaging and therapy using GNPs with multifunctional properties provides opportunities in multimodal theranostics.
bright and requires the integration of investiga-
tors, especially a clinical or an industry partner 
early in the research so that practical approaches 
could be designed to increase impact.
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